These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17212016

  • 1. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S, Abraham G, Mathew M, Somasundaram H, Muralidharan TR, Moorthy A, Sathyasekaran, Leslie N.
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [Abstract] [Full Text] [Related]

  • 2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Sep; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Sep; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE, Kutyrina IM, Shvetsov MIu.
    Ter Arkh; 2012 Sep; 84(6):21-6. PubMed ID: 22997913
    [Abstract] [Full Text] [Related]

  • 11. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J, López-Gómez JM, Aljama P.
    Nefrologia; 2005 Oct; 25(3):297-306. PubMed ID: 16053011
    [Abstract] [Full Text] [Related]

  • 16. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):753-9. PubMed ID: 15949381
    [Abstract] [Full Text] [Related]

  • 17. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
    Landray MJ, Thambyrajah J, McGlynn FJ, Jones HJ, Baigent C, Kendall MJ, Townend JN, Wheeler DC.
    Am J Kidney Dis; 2001 Sep 23; 38(3):537-46. PubMed ID: 11532686
    [Abstract] [Full Text] [Related]

  • 18. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B, Fabbian F, Giles M, Johnston A, Baker LR.
    Clin Nephrol; 1999 Dec 23; 52(6):377-82. PubMed ID: 10604646
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of anemia in predialysis chronic kidney disease patients.
    Shaheen FA, Souqiyyeh MZ, Al-Attar BA, Karkar A, Al Jazairi AM, Badawi LS, Ballut OM, Hakami AH, Naguib M, Al-Homrany MA, Barhamein MY, Ahmed AM, Khardaji MM, Said SA, Anemia Prevalence in CKD Patients Group.
    Saudi J Kidney Dis Transpl; 2011 May 23; 22(3):456-63. PubMed ID: 21566300
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.